These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

630 related items for PubMed ID: 20811753

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A comparison of aspirin and clopidogrel with or without proton pump inhibitors for the secondary prevention of cardiovascular events in patients at high risk for gastrointestinal bleeding.
    Hsiao FY, Tsai YW, Huang WF, Wen YW, Chen PF, Chang PY, Kuo KN.
    Clin Ther; 2009 Sep; 31(9):2038-47. PubMed ID: 19843493
    [Abstract] [Full Text] [Related]

  • 3. Relationship between cardiovascular outcomes and proton pump inhibitor use in patients receiving dual antiplatelet therapy after acute coronary syndrome.
    Hsiao FY, Mullins CD, Wen YW, Huang WF, Chen PF, Tsai YW.
    Pharmacoepidemiol Drug Saf; 2011 Oct; 20(10):1043-9. PubMed ID: 21823195
    [Abstract] [Full Text] [Related]

  • 4. Analysis of gastrointestinal prophylaxis in patients receiving dual antiplatelet therapy with aspirin and clopidogrel.
    Morneau KM, Reaves AB, Martin JB, Oliphant CS.
    J Manag Care Pharm; 2014 Feb; 20(2):187-93. PubMed ID: 24456320
    [Abstract] [Full Text] [Related]

  • 5. Proton-Pump Inhibitors Reduce Gastrointestinal Events Regardless of Aspirin Dose in Patients Requiring Dual Antiplatelet Therapy.
    Vaduganathan M, Bhatt DL, Cryer BL, Liu Y, Hsieh WH, Doros G, Cohen M, Lanas A, Schnitzer TJ, Shook TL, Lapuerta P, Goldsmith MA, Laine L, Cannon CP, COGENT Investigators.
    J Am Coll Cardiol; 2016 Apr 12; 67(14):1661-71. PubMed ID: 27012778
    [Abstract] [Full Text] [Related]

  • 6. [Efficacy and safety of concomitant use of rabeprazole during dual-antiplatelet therapy with clopidogrel and aspirin after drug-eluting stent implantation: a retrospective cohort study].
    Yasu T, Ikee R, Miyasaka Y, Chubachi H, Saito S.
    Yakugaku Zasshi; 2010 Dec 12; 130(12):1743-50. PubMed ID: 21139402
    [Abstract] [Full Text] [Related]

  • 7. Effects of proton pump inhibitors on adverse gastrointestinal events in patients receiving clopidogrel: systematic review and meta-analysis.
    Kwok CS, Nijjar RS, Loke YK.
    Drug Saf; 2011 Jan 01; 34(1):47-57. PubMed ID: 21047145
    [Abstract] [Full Text] [Related]

  • 8. Individualised PPI prescription in patients on combination antiplatelet therapy and upper gastrointestinal events after percutaneous coronary intervention: a cohort study.
    Häuptle R, Weilenmann D, Schneider T, Haile SR, Ammann P, Knellwolf C, Borovicka J.
    Wien Med Wochenschr; 2012 Feb 01; 162(3-4):67-73. PubMed ID: 22476595
    [Abstract] [Full Text] [Related]

  • 9. Proton pump inhibitors and other disease-based factors in the recurrence of adverse cardiovascular events following percutaneous coronary angiography: A long-term cohort.
    Ayub A, Parkash O, Naeem B, Murtaza D, Khan AH, Jafri W, Hamid S.
    Indian J Gastroenterol; 2016 Mar 01; 35(2):117-22. PubMed ID: 27056735
    [Abstract] [Full Text] [Related]

  • 10. Impact of Proton Pump Inhibitor Use on the Comparative Effectiveness and Safety of Prasugrel Versus Clopidogrel: Insights From the Treatment With Adenosine Diphosphate Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary Syndrome (TRANSLATE-ACS) Study.
    Jackson LR, Peterson ED, McCoy LA, Ju C, Zettler M, Baker BA, Messenger JC, Faries DE, Effron MB, Cohen DJ, Wang TY.
    J Am Heart Assoc; 2016 Oct 21; 5(10):. PubMed ID: 27792656
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and Safety of Proton-Pump Inhibitors in High-Risk Cardiovascular Subsets of the COGENT Trial.
    Vaduganathan M, Cannon CP, Cryer BL, Liu Y, Hsieh WH, Doros G, Cohen M, Lanas A, Schnitzer TJ, Shook TL, Lapuerta P, Goldsmith MA, Laine L, Bhatt DL, COGENT Investigators.
    Am J Med; 2016 Sep 21; 129(9):1002-5. PubMed ID: 27143321
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. One-year clinical outcome in patients with acute coronary syndrome treated with concomitant use of clopidogrel and proton pump inhibitors: results from a regional cohort study.
    Ortolani P, Marino M, Marzocchi A, De Palma R, Branzi A.
    J Cardiovasc Med (Hagerstown); 2012 Dec 21; 13(12):783-9. PubMed ID: 21252697
    [Abstract] [Full Text] [Related]

  • 14. Prognosis of concomitant users of clopidogrel and proton-pump inhibitors in a high-risk population for upper gastrointestinal bleeding.
    Wang Q, Ljung R, Lagergren J, Lu Y.
    BMC Pharmacol Toxicol; 2014 Apr 15; 15():22. PubMed ID: 24731755
    [Abstract] [Full Text] [Related]

  • 15. Impact of proton pump inhibitors and dual antiplatelet therapy cessation on outcomes following percutaneous coronary intervention: Results From the PARIS Registry.
    Chandrasekhar J, Bansilal S, Baber U, Sartori S, Aquino M, Farhan S, Vogel B, Faggioni M, Giustino G, Ariti C, Colombo A, Chieffo A, Kini A, Saporito R, Michael Gibson C, Witzenbichler B, Cohen D, Moliterno D, Stuckey T, Henry T, Pocock S, Dangas G, Gabriel Steg P, Mehran R.
    Catheter Cardiovasc Interv; 2017 Jun 01; 89(7):E217-E225. PubMed ID: 27650638
    [Abstract] [Full Text] [Related]

  • 16. Analysis of the Interaction between Clopidogrel, Aspirin, and Proton Pump Inhibitors Using the FDA Adverse Event Reporting System Database.
    Suzuki Y, Suzuki H, Umetsu R, Uranishi H, Abe J, Nishibata Y, Sekiya Y, Miyamura N, Hara H, Tsuchiya T, Kinosada Y, Nakamura M.
    Biol Pharm Bull; 2015 Jun 01; 38(5):680-6. PubMed ID: 25947914
    [Abstract] [Full Text] [Related]

  • 17. Proton pump inhibitor and clopidogrel interaction: fact or fiction?
    Laine L, Hennekens C.
    Am J Gastroenterol; 2010 Jan 01; 105(1):34-41. PubMed ID: 19904241
    [Abstract] [Full Text] [Related]

  • 18. Effect of the clopidogrel-proton pump inhibitor drug interaction on adverse cardiovascular events in patients with acute coronary syndrome.
    Bhurke SM, Martin BC, Li C, Franks AM, Bursac Z, Said Q.
    Pharmacotherapy; 2012 Sep 01; 32(9):809-18. PubMed ID: 22744772
    [Abstract] [Full Text] [Related]

  • 19. New look at antiplatelet agent-related peptic ulcer: an update of prevention and treatment.
    Hsu PI.
    J Gastroenterol Hepatol; 2012 Apr 01; 27(4):654-61. PubMed ID: 22283743
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of the antithrombotic effects of clopidogrel by proton pump inhibitors: facts or fancies?
    Lettino M.
    Eur J Intern Med; 2010 Dec 01; 21(6):484-9. PubMed ID: 21111931
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.